Jeng and colleagues observed that AURKA overexpression in HCC patients was associated with high‐grade disease (grades II–IV) and portal vein tumour invasion (stages IIIB–IV),79 representing one of the first studies to suggest a possible role for AURKA as a prognostic biomarker for HCC patients. This evidence concerns the gene AURKA and hepatocellular carcinoma.